A Study to Investigate the Safety and Pharmacokinetics of AZD6793 in Healthy Japanese and Chinese Participants
Completed · Phase 1 · Has a placebo group
Conditions studied: Healthy Participants
In brief
The main purpose of this study is to assess the safety, tolerability and pharmacokinetics (PK) of oral AZD6793 in healthy Japanese and Chinese participants.
Key facts
- Study ID
- NCT06368440
- Run by
- AstraZeneca
- People needed
- 39
- Starts
- 2024-05-15
- Expected to finish
- 2024-12-23
- Last updated by the study team
- 2025-10-24
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
Where it is running
- Research Site — Glendale, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.